Phase Ib Study of Immune Biomarker Modulation with Neoadjuvant Cetuximab and TLR8 Stimulation in Head and Neck Cancer to Overcome Suppressive Myeloid SignalsGulidanna Shayan, Robert L. Ferris, Benjamin Kansy et al.|Clinical Cancer Research|2017Cited by 80
Phase I Trial of Cetuximab, Radiotherapy, and Ipilimumab in Locally Advanced Head and Neck CancerRobert L. Ferris, Julie E. Bauman, Jessica Moskovitz et al.|Clinical Cancer Research|2022Cited by 32
Randomized Phase II Study of Concurrent Versus Sequential Pembrolizumab in Combination With Chemoradiation in Locally Advanced Head and Neck CancerDan P. Zandberg, Julie E. Bauman, James Ohr et al.|Journal of Clinical Oncology|2025Cited by 20
Definitive local therapy to head and neck squamous cell carcinoma with distant metastasisSteven Borson, Dan P. Zandberg, Yongli Shuai et al.|Laryngoscope Investigative Otolaryngology|2022Cited by 13